Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $149.7500 (-0.93%) ($146.6200 - $152.4100) on Thu. Jul. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.47% (three month average) | RSI | 41 | Latest Price | $149.7500(-0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.3% a day on average for past five trading days. | Weekly Trend | ABBV declines -0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(33%) DIA(25%) SPLV(24%) XLP(24%) VYM(23%) | Factors Impacting ABBV price | ABBV will decline at least -0.735% in a week (0% probabilities). VIXM(-15%) UUP(-13%) TBT(-3%) UNG(-1%) VXX(2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.735% (StdDev 1.47%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $151.18 | 5 Day Moving Average | $150.09(-0.23%) | 10 Day Moving Average | $149.87(-0.08%) | 20 Day Moving Average | $151.18(-0.95%) | To recent high | -4.2% | To recent low | 8.8% | Market Cap | $264.201b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |